These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 27061166)

  • 1. Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
    Stampacchia G; Gerini A; Mazzoleni S
    NeuroRehabilitation; 2016 Apr; 38(4):385-93. PubMed ID: 27061166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
    Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
    Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of intrathecal baclofen in multiple sclerosis.
    Natale M; D'Oria S; Nero VV; Squillante E; Gentile M; Rotondo M
    Clin Neurol Neurosurg; 2016 Apr; 143():121-5. PubMed ID: 26922704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal baclofen for muscle spasticity and pain--two case reports.
    Al Khudhairi D; Rababa A; Saddiqui MN
    Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537
    [No Abstract]   [Full Text] [Related]  

  • 6. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
    Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early outcomes after intrathecal baclofen therapy in ambulatory patients with multiple sclerosis.
    Lee BS; Jones J; Lang M; Achey R; Dai L; Lobel DA; Nagel SJ; Machado AG; Bethoux F
    J Neurosurg; 2018 Oct; 129(4):1056-1062. PubMed ID: 29192855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal Baclofen Infusion-Botulinum Toxin Combined Treatment Efficacy in the Management of Spasticity due to Cerebral Palsy.
    Marvulli R; Lagioia G; Ianieri G; Dell'Olio L; Zonno A; Riccardi M; Sinisi RB; Rizzo LB; Farì G; Megna M; Ranieri M
    CNS Neurol Disord Drug Targets; 2024; 23(7):917-926. PubMed ID: 38213169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrathecal baclofen in severe spasticity due to multiple sclerosis].
    Sławek J; Zieliński P; Hołub-Kucharska W; Kaniszewska J; Paczkowska M; Słoniewski P
    Neurol Neurochir Pol; 2003; 37(5):1135-42; discussion 1143. PubMed ID: 15174259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.
    Postma TJ; Oenema D; Terpstra S; Bouma J; Kuipers-Upmeijer H; Staal MJ; Middel BJ
    Pharmacoeconomics; 1999 Apr; 15(4):395-404. PubMed ID: 10537958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity.
    Sadiq SA; Wang GC
    J Neurol; 2006 May; 253(5):563-9. PubMed ID: 16328111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients.
    Plassat R; Perrouin Verbe B; Menei P; Menegalli D; Mathé JF; Richard I
    Spinal Cord; 2004 Dec; 42(12):686-93. PubMed ID: 15303111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy.
    Kraus T; Gegenleitner K; Svehlik M; Novak M; Steinwender G; Singer G
    Eur J Paediatr Neurol; 2017 May; 21(3):565-569. PubMed ID: 28237420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life: effect of reduced spasticity from intrathecal baclofen.
    Gianino JM; York MM; Paice JA; Shott S
    J Neurosci Nurs; 1998 Feb; 30(1):47-54. PubMed ID: 9604822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.
    Sammaraiee Y; Yardley M; Keenan L; Buchanan K; Stevenson V; Farrell R
    Mult Scler Relat Disord; 2019 Jan; 27():95-100. PubMed ID: 30366276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
    Albright AL; Gilmartin R; Swift D; Krach LE; Ivanhoe CB; McLaughlin JF
    J Neurosurg; 2003 Feb; 98(2):291-5. PubMed ID: 12593613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients.
    Ben Smail D; Peskine A; Roche N; Mailhan L; Thiébaut I; Bussel B
    Mult Scler; 2006 Feb; 12(1):101-3. PubMed ID: 16459726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen.
    Dressnandt J; Conrad B
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):168-73. PubMed ID: 8708647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.